K

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Director – Clinical Data Management

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • At least 10 years of clinical data management experience in the pharmaceutical or biotechnology industry, or at least 8 years with an advanced degree.
  • A proven track record providing strategic data management leadership across late-stage development programs while ensuring data integrity, data quality, and inspection readiness.
  • Expert knowledge of clinical trial data management, including CDASH standards, database lock execution, external data reconciliation (such as eCOA, central labs, and PK), inspection readiness, regulatory guidelines (such as ICH and GCP), and internal SOPs.
  • Deep expertise in global CRO oversight, vendor management, and strategic outsourcing models to ensure high-quality deliverables, timeline adherence, and cost control.
  • Demonstrated experience with eTMF systems and Data Management documentation requirements.
  • Strong command of electronic data capture systems and clinical data warehousing technologies, with experience across a range of clinical data management platforms.
  • A Bachelor’s degree in Life Sciences or a related field.

Responsibilities

  • Lead vendor oversight activities across global development programs, ensuring alignment between the company and CROs on all data management deliverables.
  • Provide program-level leadership and oversight of clinical data management activities, and monitor and report on program and study progress.
  • Represent the Data Management function on the study team, fostering cross-functional collaboration and clear expectations.
  • Monitor vendor performance and quality metrics, escalate issues to management, and drive resolution strategies.
  • Proactively identify risks and develop and implement mitigation or corrective action plans.
  • Ensure Data Management Trial Master File documentation is filed accurately and maintained in an inspection-ready state.
  • Support study-level inspection readiness and audit preparation efforts.

Desired Qualifications

  • Experience in cardiometabolic disease areas.
  • Experience with large clinical trial data sets.
  • A track record leading Data Management activities through successful global health authority filings (NDA, BLA, or MAA) and health authority interactions.

About the Company

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Kailera Therapeutics focuses on obesity and related metabolic conditions by acquiring and developing clinical-stage drug candidates and moving them toward commercialization. Its lead asset, KAI-9531, is an injectable dual agonist of GLP-1 and GIP receptors for obesity and type 2 diabetes, and the pipeline includes an oral GLP-1 agonist (KAI-7535), an oral tablet form of KAI-9531, and an injectable tri-agonist targeting GLP-1, GIP, and glucagon receptors (KAI-4729). The company differentiates itself by sourcing assets outside of early research, pursuing a mix of injectable and oral therapies, and leveraging a high-profile leadership team and substantial funding to progress a broad portfolio under external licenses. Kailera’s goal is to advance multiple metabolic disease therapies from clinical development toward commercialization to improve outcomes for patients with obesity and related conditions.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Kailera Therapeutics

See more jobs